
Research ArticleRandomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders
Keywords: HCV; hepatitis C virus; PegIFNα; pegylated interferon alfa-2a; RBV; ribavirin; SVR; sustained virologic response; QUAD; quadruple; DAA; direct-acting antiviral; SVR24; sustained virologic response at 24 weeks post-treatment; LLOQ; lower limit of quantif